Fundraising Fox

Peter Emtage

Investor

Venture Partner at Versant Ventures

San Francisco Bay Area

Writes $100K – $5M checks Β· typically $1.5M

FoundedSanta Ana Bio

About

Peter Emtage joined Versant Ventures as an Entrepreneur-in-Residence in October 2020 and became a Venture Partner in April 2021. He previously led cell therapy research at Kite Pharma (a Gilead company) and held senior scientific roles at Cell Design Labs and MedImmune, with over 20 years of drug development experience in oncology, autoimmunity, infectious diseases and inflammation.

Experience

  1. Santa Ana Bio, IncChief Executive Officercurrent2021 β€” present
  2. Versant VenturesVenture Partnercurrent2020 β€” present
  3. Kite PharmaGlobal Head of Cell Therapy Research2018 β€” 2020
  4. Cell Design LabsChief Scientific Officer2016 β€” 2018San Francisco, California

Skills & more

IND1Clinical Development99Biochemistry46Infectious Diseases23Cell Culture19GLP8Drug Discovery99GMP6Clinical Research10FDA13Antibodies13Vaccines6
+12 morePharmacologyBiologicsBiotherapeuticsAssay DevelopmentInflammationAutoimmunityOncologyBiomarker DiscoveryBiotechnologyBiopharmaceuticalsCancerCell

Languages English

From Peter's professional profile.

Shared employers

Colleagues at Versant Ventures